Top in cardiology: Cardiometabolic health worsens in US; dangers of smoking and masking
The prevalence of optimal cardiometabolic health among U.S. adults declined in the past 2 decades, and researchers found persistent disparities based on age, sex, education and race.
They observed the trend by utilizing the National Health and Nutrition Examination Survey, evaluating optimal levels of adiposity, blood glucose, blood lipids, BD and clinical CVD among over 55,000 adults. It was the top story in cardiology last week.
Another top story was about a study that showed the re-inhalation of carbon monoxide among smokers who wore masks for extended periods caused vascular dysfunction.
Read these and more top stories in cardiology below:
Declines in US cardiometabolic health ‘striking’; disparities persist over 2 decades
The prevalence of optimal cardiometabolic health among U.S. adults declined in the past 2 decades, with disparity gaps widening based on age, sex, education and race, researchers reported. Read more.
Smoking while wearing mask may promote vascular dysfunction, worsening cardiovascular health
The re-inhalation of carbon monoxide among smokers while wearing a mask promotes vascular dysfunction and may worsen cardiovascular health, according to findings from a single-center study. Read more.
Historical ‘redlining’ practices associated with worse cardiometabolic disease
Historical housing discriminatory practices are associated with modern-day cardiometabolic disease and risk factors years after such practices were outlawed, according to an analysis of census-level data. Read more.
Angiotensin receptor blockers may lower risk for progression to dementia
Angiotensin receptor blockers may reduce progression from mild cognitive impairment to dementia in patients undergoing antihypertensive treatment, researchers wrote in Hypertension. Read more.
Heart failure ‘most expensive’ comorbidity, exceeding $22B per year
An additional $22.3 billion is spent nationally on heart failure-related medical services each year, with the total annual expenditure for adults with heart failure approaching $180 billion, according to an analysis of Medical Expenditure Panel Survey data. Read more.